These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4218488)

  • 21. [Hypercholesterolemia and the diagnosis and management of hyper- lipidemia in adults. Recommendations of the working groups of the Finnish Society of Internal Medicine and the Finnish Cardiology Society].
    Duodecim; 1988; 104(18):1425-38. PubMed ID: 3181045
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preliminary studies on the effects of CoA administration on plasmatic lipids in man].
    Arrigo F; Vitale D; Consolo F
    Boll Soc Ital Biol Sper; 1973 Mar; 49(5):305-10. PubMed ID: 4786567
    [No Abstract]   [Full Text] [Related]  

  • 23. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W
    MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
    [No Abstract]   [Full Text] [Related]  

  • 24. [AVERT study (Atorvastatin Versus Revascularization Treatment). Clinical advantage of aggressive lipid lowering].
    Z Kardiol; 1999 Mar; 88(3 Suppl):1-4. PubMed ID: 10330699
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy of atherosclerosis: lipid regulation and direct anti-atherosclerotic effect].
    Internist (Berl); 1998 Oct; 39(10 Suppl Lipidregul):1-4. PubMed ID: 9810870
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of sodium d-thyroxine on the hiperlipedemia, hypercholesteremia, triglycerides and serum lipoproteins in patients with arteriosclerosis].
    Mazzei ES; Mazzei CM; Gotelli C
    Prensa Med Argent; 1967 Mar; 54(5):199-203. PubMed ID: 5605172
    [No Abstract]   [Full Text] [Related]  

  • 27. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    De Vries HR; Bijvoet OL
    Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antilipemics and atherosclerosis].
    Chiche P; Chekler P; Ribadeau-Dumas JL; Derrida R
    Coeur Med Interne; 1967 Apr; 6(2):235-43. PubMed ID: 5618970
    [No Abstract]   [Full Text] [Related]  

  • 30. [Beyond cholesterol levels: new therapeutic indications of statins].
    De Luca N
    Recenti Prog Med; 2001; 92(7-8):429-32. PubMed ID: 11475783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The MeOH extract of Pleurospermum kamtschaticum and its active component buddlejasaponin (IV) inhibits intrinsic and extrinsic hyperlipidemia and hypercholesterolemia in the rat.
    Jung HJ; Nam JH; Park HJ; Lee KT; Park KK; Kim WB; Choi J
    J Ethnopharmacol; 2007 Jun; 112(2):255-61. PubMed ID: 17433587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental and clinical studies on the effect of Trimanyl on lipid metabolism. II. The effect of a single dose of the preparation on the level of total cholesterol and its fractions in the blood serum].
    Janicki K; Szczeciakowska L; Gurda M
    Przegl Lek; 1968; 24(12):874-7. PubMed ID: 5704541
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hypolipemic effects of 1-10(hydroxy-2 ethylthio) decane (LL1558), based on 77 cases of essential hyperlipidemia].
    Rouffy J; Loeper J
    Therapie; 1972; 27(3):433-44. PubMed ID: 4570211
    [No Abstract]   [Full Text] [Related]  

  • 34. Disodium etidronate therapy for dystrophic cutaneous calcification.
    Rabens SF; Bethune JE
    Arch Dermatol; 1975 Mar; 111(3):357-61. PubMed ID: 804294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate].
    Barisone D; Gallo G; Accardo S
    Minerva Med; 1969 Jan; 60(6):174-80. PubMed ID: 5776766
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of a diphosphonate in para-articular ossifications after total hip replacement. A clinical study.
    Slooff TJ; Feith R; Bijvoet OL; Nollen AJ
    Acta Orthop Belg; 1974; 40(5-6):820-8. PubMed ID: 4219966
    [No Abstract]   [Full Text] [Related]  

  • 37. Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review.
    Carlson LA
    J Intern Med; 2005 Aug; 258(2):94-114. PubMed ID: 16018787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Activity of a phospholipid association on serum lipoproteins and on cholesteremia].
    Rossi F; Bordo D
    Minerva Med; 1967 Jul; 58(57):2608-16. PubMed ID: 6057206
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypolipemic activity of 1,2-alpha-oxido-4,6-androstadiene-3,17 dione (Compound 51).
    Linèt O
    Arzneimittelforschung; 1969 Nov; 19(11):1899-900. PubMed ID: 5395665
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum lipid disorders: what levels should you aim for?
    Rees ED
    Geriatrics; 1981 Feb; 36(2):77-86. PubMed ID: 7450512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.